{"transactions":[{"id":4549462,"issuer":{"id":6045,"kind":"organization","name":"Lineage Cell Therapeutics, Inc."},"owners":[{"id":180377,"kind":"person","name":"KNIGHT JAMES A.","position":1,"cik":"0001690272","reported_name":"KNIGHT JAMES A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr VP, Head of Corporate Dev"}}],"security":"Option to Purchase Common Shares","published_at":"2016-11-19T01:58:38.000Z","date":"2016-10-19","kind":"grant","acquired":true,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One quarter of the options shall vest on October 18, 2017, subject to the completion of 12 months of continuous employment from the date of grant on October 19, 2016, and the balance shall vest in 36 monthly installments upon the completion of each month of continuous employment from the first anniversary of the date of grant."}],"balance_after":300000,"derivative":{"exercise_price":3.49,"expiration_date":"2026-10-18","underlying":"Common Shares","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0001209191-16-151321","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/876343/000120919116151321/doc4.xml","form_type":"4"}}]}